Poll

Poll results: Do you believe biosimilars have the same efficacy as branded medications?

Results from our recent poll indicate a mixed bag of responses from ophthalmologists.

Ophthalmology Times® polled our audience with the following question from December 3, 2022 to December 16, 2022:​ Do you believe biosimilars have the same efficacy as branded medications?

The poll appeared on OphthalmologyTimes.com and was promoted in our e-newsletters during this time. Results show a mixed bag of responses.

58 responses were recorded, in total. Of these:

43% responded, "Yes."

28% responded, "No."

29% responded, "Unsure."

.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
(Image credit: Ophthalmology Times) AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhD
(Image credit: Ophthalmology Times) AGS 2025: Long-term efficacy and safety of standalone and phaco ELT with Marc Toeteberg-Harms, MD
© 2025 MJH Life Sciences

All rights reserved.